We’re Eco-designing, from R&D to Commercialization

All our new products will be eco-designed by 2025, and all top-20-selling products by 2030.

Diversity, Equity, and Inclusion Report

In the first full year of our new People and Culture strategy, Diversity, Equity, and Inclusion took center stage. This report celebrates the tangible progress we’ve made towards reflecting diversity in our leadership, unleashing the full potential of our people, and achieving impact in and beyond the workplace.

Making sense of MS

The powerful role of words and communication. In the last 10 years alone, the scientific understanding of MS has evolved significantly, and so has the way we talk about the disease. 

Our Integrated Report 2022

Discover how we’re making the impossible possible to improve people's lives everywhere. 

Meet Naimish Patel

Jamming at home with his daughters, Naimish admits he would have loved to have become a professional musician, but instead he channeled his curiosity into the world of research to unravel the complicated process of chasing the miracles of science to improve people’s lives.

Finding Hope in Inclusive Clinical Trials

Everyone should have the opportunity to be included in clinical research – especially people from communities that are historically underrepresented in these studies. We are determined to make our clinical trials inclusive by design and ensure that they represent the diversity of the patient populations living with each disease we aim to treat.

Rethinking the Science of COPD

Chronic obstructive pulmonary disease (COPD) is the third most common cause of death worldwide. Learn how we are working to transform the way COPD is understood and treated in partnership with Regeneron.

Sanofi Today

Social Impact

June 5, 2023

We’re Eco-designing, From R&D to Commercialization

Our latest news

June 2, 2023
Media Update: New data from Sanofi’s diverse, differentiated oncology pipeline and portfolio to be presented at ASCO 2023
June 1, 2023
Press Release: Sanofi launches 2023 global Employee Stock Purchase Plan  
May 31, 2023
Press Release: Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis
May 25, 2023
Press Release: Annual General Meeting of May 25, 2023 – Frédéric Oudéa new Chairman of the Board of Directors

Explore More

Sanofi X Paris 2024

Igniting the Potential in Everyone

Our Legacy

Our company of today is built on a heritage of turning the impossible into the possible.

First quarter 2023 results

Strong Q1 growth driven by Specialty Care, Vaccines and CHC.

Explore Career Opportunities

You'll be surprised what you can achieve at Sanofi. Discover your future here.